---
title: 'Allogeneic hematopoietic stem-cell transplantation for patients with Richter
  transformation: a retrospective study on behalf of the Chronic Malignancies Working
  Party of the EBMT'
date: '2024-03-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38503942/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240320180609&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Management of Richter transformation (RT) is particularly challenging,
  with survival estimates <1 year. We report on outcomes of 66 RT patients undergoing
  allogeneic-HCT (allo-HCT) between 2008 and 2018 registered with the EBMT. Median
  age at allo-HCT was 56.2 years (interquartile range (IQR), 51.3-63.1). Median time
  from RT to allo-HCT was 6.9 months (IQR, 4.9-11) and 28 (42.4%) were in complete
  remission (CR). The majority underwent reduced intensity conditioning (66.2%) using
  peripheral ...
disable_comments: true
---
Management of Richter transformation (RT) is particularly challenging, with survival estimates <1 year. We report on outcomes of 66 RT patients undergoing allogeneic-HCT (allo-HCT) between 2008 and 2018 registered with the EBMT. Median age at allo-HCT was 56.2 years (interquartile range (IQR), 51.3-63.1). Median time from RT to allo-HCT was 6.9 months (IQR, 4.9-11) and 28 (42.4%) were in complete remission (CR). The majority underwent reduced intensity conditioning (66.2%) using peripheral ...